Check Claims Before You Publish

Author identity ambiguous — two different scientific profiles named "Charles L. Bennett"

Evidence shows (A) a high‑impact astrophysics/cosmology Charles L. Bennett (leader/first author on WMAP papers with very large citation counts) and (B) a biomedical/oncology Charles L. Bennett with a smaller publication set (h≈17, ~1,638 citations, 27 papers in the supplied list). These are distinct author identities and must not be conflated when assessing scientific strength.

Astrophysics example (high-impact, WMAP): WMAP 2003 (high-impact)

Biomedical example (oncology/health-services): ASCO guidelines survey (2003)

For a careful author review I recommend specifying which Charles L. Bennett (ORCID or institutional affiliation) you want assessed; otherwise conclusions will mix incompatible profiles and mislead.

Author Review — Charles L. Bennett (ambiguity warning + comparative visual analysis)

Visualize first: two distinct scientific footprints appear in the data you supplied — one is a field‑defining astrophysicist (WMAP leader) and another is a biomedical/oncology researcher active in clinical epidemiology, pharmacoeconomics, and cancer supportive‑care topics. Treat these as separate targets for fair evaluation.

What the visual shows (concise):

• At least one profile (OpenAlex A5065163729) corresponds to a high‑impact cosmology author (very large citation counts; numerous highly cited WMAP papers) — this is the CMB/WMAP scientist whose work reshaped cosmology (WMAP 2003 (high-impact)).
• Another supplied profile (your Author Citation Information: h-index 17, 1,638 citations, 27 papers) maps to a biomedical researcher active in oncology, pharmacoeconomics and infectious disease outcomes — see representative papers in your list (e.g., ASCO guideline survey) (ASCO guidelines survey (2003)).

Detailed evidence synthesis (key points, inline-cited)

1. Author disambiguation is mandatory. Bibliometric aggregates supplied include multiple OpenAlex matches for "Charles L. Bennett" with widely divergent metrics (works_count, cited_by_count, h_index). Conflating them will produce incorrect assessments. Example: WMAP leader (OpenAlex match with works_count=441, cited_by_count=63,356, h_index=68) vs supplied biomedical profile (h_index=17, 1,638 citations). Treat as separate individuals before scoring or hiring/credit decisions.
2. Scientific impact vs domain: The WMAP papers are field‑defining in observational cosmology (multiple top‑tier, highly cited journal articles from 1992–2011; see WMAP 1‑, 3‑, 5‑, 7‑year results cited massively) (WMAP 2003 (high-impact)).
3. Biomedical profile strengths & limitations: The supplied biomedical publications span clinical‑epidemiology, cost‑effectiveness, and supportive‑care/hemato‑oncology topics (examples: ASCO guideline survey; ADAMTS13 review). These are applied clinical research contributions with variable study designs (surveys, cost‑analyses, reviews), useful for practice/policy but typically lower citation volume than major basic‑science discoveries (ADAMTS13 review (2005)).
4. Study quality & reproducibility concerns to check per paper: for many biomedical items in the supplied list (surveys, cost‑effectiveness analyses, pharmacovigilance reports) examine sample size, response bias, confounding control, pre‑registration, and availability of underlying data; the ASCO guideline survey explicitly documents response rates and nonresponse limitations (ASCO survey details).
5. Signal vs noise in bibliometrics: citation counts and h‑index vary by field and era. High h‑index/citation counts for the astrophysics C.L. Bennett reflect long‑running, collaborative, observational programs (WMAP) where large team papers accumulate many citations; this does not directly translate to methodological reproducibility in unrelated biomedical domains. Conversely, biomedical work with modest h values may still be high quality within its domain if methods are robust and clinically relevant.

Practical, evidence‑based recommendation for accurate author assessment

1. Resolve identity: provide ORCID, institutional affiliation, or at least a representative DOI to lock the author record before scoring.
2. Evaluate domain‑appropriate metrics: for basic science, prioritize first/last author, independent replication, data availability, and methods transparency; for clinical research, prioritize sample representativeness, confounding control, pre-registration, and patient‑relevant outcomes.
3. Inspect representative papers directly for methodological rigor (I can fetch and synthesize full‑text evidence per paper if you choose a specific author identity).

Representative citations used in this review (selected)

• WMAP 2003 (high-impact)
• ASCO guidelines survey (2003)
• ADAMTS13 review (2005)
• Parkinson

What would change my main conclusions (i.e., falsifiers)

• If you provide an ORCID or institutional affiliation that unambiguously identifies which Charles L. Bennett you mean, the analysis will be re-centered and scores will materially change.
• If underlying full texts reveal serious reproducibility problems (undisclosed conflicts of interest, missing methods, undeclared data manipulation), then even high bibliometrics would be downgraded.

Next step: tell me which specific Charles L. Bennett (provide ORCID or pick a representative DOI from the list) and I will produce a targeted, paper‑level, reproducibility‑focused critique with direct figure reproductions and exact methodological scoring.